Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
Ann Oncol. 2019 Jan 1;30(1):68-75. doi: 10.1093/annonc/mdy470.
Ann Oncol. 2019.
PMID: 30407504
Free article.